PTGS2 and gastric ulcer: Although the inhibition of COX1 is associated with gastric ulceration, the subsequent inhibition of COX2 is well-established to be anti-inflammatory through the inhibition of prostaglandin formation, with NSAIDs working through this pathway [15].